The Association for Diagnostics & Laboratory Medicine (formerly AACC) supports Rep. Cassidy’s letter asking the FDA to explain how it plans to abide by the recent Supreme Court decision curtailing the power of federal agencies
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))On June 28, in Loper Bright Enterprises v. Raimondo, the Supreme Court overturned the so-called Chevron doctrine and reinforced that Congress and the courts are responsible for writing and interpreting laws, respectively, not federal agencies. In response to this landmark decision, Representative Bill Cassidy, MD (R-La.), sent a letter to the Food and Drug Administration (FDA) today asking how the agency plans to implement this new framework, especially considering the fact that, under this new ruling, many of the agency’s actions in recent years are now officially considered to be outside the bounds of its authority.